Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Genomics of papillary thyroid carcinoma (PTC): an interview with Professor Thomas J. Giordano

There are two types of thyroid cells and therefore there are two broad types of thyroid cancer. Medullary carcinoma is derived from parafollicular or C cells, whereas follicular cells give rise to several types of thyroid cancers.

4 Feb 2015

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

You can’t see it, hear it or smell it, and it’s constantly changing: but despite that, Australia’s nuclear scientists have figured out how to more accurately measure the unit of activity for radionuclides, the Becquerel (Bq).

6 Jan 2015

New Cancer Council data finds fivefold increase in thyroid cancer rates

New Cancer Council data has found a fivefold increase in rates of thyroid during the past 30 years in Queensland, with nearly 500 Queenslanders diagnosed in 2012 compared to less than 50 diagnoses in 1982.

12 Dec 2014

New approach to fighting breast, thyroid cancers

A team of researchers from the University of Alberta has discovered a new approach to fighting breast and thyroid cancers by targeting an enzyme they say is the culprit for the "vicious cycle" of tumour growth, spread and resistance to treatment.

24 Nov 2014

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.

17 Nov 2014

Study on papillary thyroid carcinoma to be presented at 84th Annual Meeting of the ATA

The prevalence of papillary thyroid carcinoma (PTC), the most common type of thyroid cancer, is increasing rapidly. New research to determine the impact of radioactive iodine (RAI) therapy on survival in PTC, describing a novel blood test able to detect circulating BRAFV600E-positive tumor DNA, and identifying a long non-coding RNA specifically associated with the thyroid that is down-regulated in PTC compared to normal thyroid tissue in patient-derived clinical specimens and cell cultures will be featured in oral presentations delivered at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.

30 Oct 2014

Novel therapeutic approaches to improve thyroid cancer outcomes

Novel therapeutic approaches to improve outcomes in thyroid cancer, for example using targeted delivery of cytotoxic drugs to tumor cells, will be among the topics featured in oral and poster presentations delivered at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.

30 Oct 2014

New research findings on Graves' disease to be highlighted at ATA meeting

A unique mouse model of Graves' disease, an autoimmune disorder that causes hyperthyroidism, and new research findings that may help improve the treatment of Graves' disease will be highlighted in oral and poster presentations at the 84th Annual Meeting of the American Thyroid Association, October 29-November 2, 2014, in Coronado, California.

30 Oct 2014

Understanding of genomic landscape of thyroid cancer

A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.

27 Oct 2014

Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas (PTC) – the most common form of thyroid cancer – has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development.

25 Oct 2014

Scientists identify new biomarker for diagnosing cause of thyroid cancer

The expression of the protein CLIP2 provides information on whether a papillary thyroid carcinoma was induced by radiation or had a sporadic origin. With this discovery, scientists from the Helmholtz Zentrum München have identified a new biomarker for the diagnosis of the cancer cause.

7 Oct 2014

Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

A new study from researchers at Henry Ford Hospital in Detroit finds widespread vitamin D deficiency among patients who undergo a thyroidectomy, potentially putting them at greater risk for developing dangerously low blood calcium levels after surgery.

26 Sep 2014

Dominica Anderson named recipient of 2014 Julie and Ben Rogers Award for Excellence in Patient Care

Dominica Anderson, a nursing assistant at The University of Texas MD Anderson Cancer Center, is the 2014 recipient of the Julie and Ben Rogers Award for Excellence in Patient Care.

17 Sep 2014

Incidence of thyroid cancer rising faster in Pennsylvania than in rest of the United States as a whole

Incidence of thyroid cancer is rising faster in Pennsylvania than in the rest of the United States as a whole, according to Penn State College of Medicine researchers.

11 Sep 2014

Overweight and obesity linked to 10 common cancers and over 12 000 cases every year in the UK

A higher body mass index (BMI) increases the risk of developing 10 of the most common cancers, the largest study of its kind on BMI and cancer, involving more than 5 million adults in the UK, published in The Lancet shows.

14 Aug 2014

Molecular testing panel increases likelihood of performing correct surgery for thyroid cancer patients

The routine use of a molecular testing panel developed at UPMC greatly increases the likelihood of performing the correct initial surgery for patients with thyroid nodules and cancer, report researchers from the University of Pittsburgh Cancer Institute (UPCI), partner with UPMC CancerCenter.

26 Jul 2014

Bayer announces Health Canada approval of Nexavar for differentiated thyroid cancer treatment

Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally advanced or metastatic, progressive, differentiated thyroid carcinoma (DTC), refractory to radioactive iodine (RAI).

7 Jul 2014

Highmark, Horizon issued positive coverage policies for Afirma Gene Expression Classifier

Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, today announced that two Blue Cross Blue Shield–affiliated organizations, Highmark Inc. and Horizon Blue Cross Blue Shield of New Jersey, have issued positive coverage policies for the company's Afirma Gene Expression Classifier (GEC).

3 Jul 2014

People with significant hypothyroidism can experience impaired driving

People with significant hypothyroidism can experience impaired driving similar to those who are driving when intoxicated by alcohol, a new study finds.

23 Jun 2014

Experts from 96 countries gather in Chicago to attend ICE/ENDO 2014

ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society, has tallied more registrants than any other annual meeting in the Endocrine Society's nearly 100-year history.

23 Jun 2014

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Genomics of papillary thyroid carcinoma (PTC): an interview with Professor Thomas J. Giordano

ANSTO launches nuclear medicine program to improve diagnosis, treatment of cancer and heart disease

New Cancer Council data finds fivefold increase in thyroid cancer rates

New approach to fighting breast, thyroid cancers

Sanofi, Genzyme announce FDA approval of Lemtrada for treatment of relapsing forms of MS

Study on papillary thyroid carcinoma to be presented at 84th Annual Meeting of the ATA

Novel therapeutic approaches to improve thyroid cancer outcomes

New research findings on Graves' disease to be highlighted at ATA meeting

Understanding of genomic landscape of thyroid cancer

Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

Scientists identify new biomarker for diagnosing cause of thyroid cancer

Study on widespread vitamin D deficiency among patients who undergo thyroidectomy

Dominica Anderson named recipient of 2014 Julie and Ben Rogers Award for Excellence in Patient Care

Incidence of thyroid cancer rising faster in Pennsylvania than in rest of the United States as a whole

Overweight and obesity linked to 10 common cancers and over 12 000 cases every year in the UK

Molecular testing panel increases likelihood of performing correct surgery for thyroid cancer patients

Bayer announces Health Canada approval of Nexavar for differentiated thyroid cancer treatment

Highmark, Horizon issued positive coverage policies for Afirma Gene Expression Classifier

People with significant hypothyroidism can experience impaired driving

Experts from 96 countries gather in Chicago to attend ICE/ENDO 2014

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Thyroid Cancer News and Research

Latest Thyroid Cancer News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in